Samantha Y Lewis

US Patent:

20040058365, Mar 25, 2004

Filed:

Jul 11, 2003

Appl. No.:

10/466164

Inventors:

Scott Panzer - Sunnyvale CA, US
Stephen Lincoln - Potomac MD, US
Christina Altus - Campbell CA, US
Gerard Dufour - Castro Valley CA, US
Jennifer Jackson - Santa Cruz CA, US
Anissa Jones - San Jose CA, US
Tam Dam - San Jose CA, US
Tommy Liu - Daly City CA, US
Bernard Harris - Sunnyvale CA, US
Vincent Flores - Union City CA, US
Abel Daffo - San Jose CA, US
Rakesh Marwaha - Burnaby, BR
Alice Chen - San Jose CA, US
Simon Chang - Sunnyvale CA, US
Edward Gerstin Jr - San Jose CA, US
Careyna Peralta - Santa Clara CA, US
Marie David - Daly City CA, US
Samantha Lewis - San Leandro CA, US

International Classification:

C12Q001/68
C07H021/04
C12P019/34
C12P021/02
C12N005/06
C07K014/00

US Classification:

435/006000, 536/023200, 435/091200, 435/069100, 435/320100, 435/325000, 530/350000

Abstract:

The present invention provides purified disease detection and treatment molecule polynucleotides (mddt). Also encompassed are the polypeptides (MDDT) encoded by mddt. The invention also provides for the use of mddt, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing mddt for the expression of MDDT. The invention additionally provides for the use of isolated and purified MDDT to induce antibodies and to screen libraries of compounds and the use of anti-MDDT antibodies in diagnostic assays. Also provided are microarrays containing mddt and methods of use.

US Patent:

20040115629, Jun 17, 2004

Filed:

Jul 9, 2003

Appl. No.:

10/250889

Inventors:

Scott Panzer - Sunnyvale CA, US
Stephen Lincoln - Potomac MD, US
Christina Altus - Campbell CA, US
Gerard Dufour - Castro Valley CA, US
Jennifer Jackson - Santa Cruz CA, US
Anissa Jones - San Jose CA, US
Tam Dam - San Jose CA, US
Tommy Liu - Daly City CA, US
Bernard Harris - Sunnyvale CA, US
Vincent Flores - Union City CA, US
Abel Daffo - San Jose CA, US
Rakesh Marwaha - Burnaby, CA
Alice Chen - San Jose CA, US
Simon Chang - Sunnyvale CA, US
Edward Gerstin - San Jose CA, US
Careyna Peralta - Santa Clara CA, US
Marie David - Daly City CA, US
Samantha Lewis - San Leandro CA, US

International Classification:

C12Q001/68
C07H021/04
C07K014/47

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

The present invention provides purified human polynucleotides for diagnostics and therapeutics (dithp). Also en-compassed are the polypeptides (DITHP) encoded by dithp. The invention also provides for the use of dithp, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing dithp for the expression of DITHP. The invention additionally provides for the use of isolated and purified DITHP to induce antibodies and to screen libraries of compounds and the use of anti-DITHP antibodies in diagnostic assays. Also provided are microarrays containing dithp and methods of use.

US Patent:

20040166500, Aug 26, 2004

Filed:

Jul 15, 2003

Appl. No.:

10/466531

Inventors:

Scott Panzer - Sunnyvale CA, US
Stephen Lincoln - Potomac MD, US
Christina Altus - Campbell CA, US
Gerard Dufour - Castro Valley CA, US
Jennifer Jackson - Santa Cruz CA, US
Anissa Jones - San Jose CA, US
Tam Dam - San Jose CA, US
Tommy Liu - Daly City CA, US
Bernard Harris - Sunnyvale CA, US
Vincent Flores - Union City CA, US
Abel Daffo - San Jose CA, US
Rakesh Marwaha - Burnaby, CA
Alice Chen - San Jose CA, US
Simon Chang - Sunnyvale CA, US
Edward Gerstin Jr - San Jose CA, US
Careyna Peralta - Santa Clara CA, US
Marie David - Daly City CA, US
Samantha Lewis - San Leandro CA, US

International Classification:

C12Q001/68
C07H021/02
C07H021/04

US Classification:

435/006000, 536/023100, 536/024300

Abstract:

The present invention provides purified secretory polynucleotides (sptm). Also encompassed are the polypeptides (SPTM) encoded by sptm. The invention also provides for the use of sptm, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing sptm for the expression of SPTM. The invention additionally provides for the use of isolated and purified SPTM to induce antibodies and to screen libraries of compounds and the use of anti-SPTM antibodies in diagnostic assays. Also provided are microarrays containing sptm and methods of use.

US Patent:

20030165540, Sep 4, 2003

Filed:

May 4, 2001

Appl. No.:

09/849729

Inventors:

Jen-Kuei Liu - Palo Alto CA, US
Samantha Lewis - San Francisco CA, US
Hans-Georg Batz - Tutzing, DE
Latha Ramaswamy - San Jose CA, US
Roy Bohenzky - Mountain View CA, US
Yu-Huei Lin - Sunnyvale CA, US
Janine Montiel - Fremont CA, US
Benjamin Chen - Fremont CA, US

International Classification:

A61K039/29
C12Q001/70
C07H021/04
C12N007/00

US Classification:

424/225100, 435/005000, 536/023720, 435/235100

Abstract:

The invention relates to a new virus, designated H101.c33 or Sentinel Virus II (SVII). Isolated SVII viruses, polynucleotides and proteins from SVII viruses, and antibodies which bind SVII virus and SVII viral proteins are provided. The polynucleotides, proteins, and antibodies of the invention may be used to detect SVII virus or infection by SVII virus in a susceptible individual. Additionally, polynucleotides of the invention may be inserted into recombinant expression vectors for recombinant production of viral proteins.